3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Bile Duct Neoplasms
1
Interventions
Specimen Handling
116
pembrolizumab
112
Magnetic Resonance Spectroscopy
99
Carboplatin
83
Cyclophosphamide
70
Biopsy
63
Cisplatin
59
Paclitaxel
56
Bevacizumab
56
Gemcitabine
48
Nivolumab
45
fludarabine
39
Dexamethasone
37
atezolizumab
36
Rituximab
36
Pemetrexed
36
Fluorouracil
36
Docetaxel
35
Leucovorin
32
Doxorubicin
31
venetoclax
30
Radiotherapy
30
Oxaliplatin
29
Capecitabine
29
Temozolomide
27
Prednisone
26
Cetuximab
26
130-nm albumin-bound paclitaxel
25
Standard of Care
24
Letrozole
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Stents
×
30 days
×
Clear all
NCT06274879
2026-05-26
Ablatio
Insel Gruppe AG, University Hospital Bern
Phase 2
Recruiting
36 enrolled